High throughput screening of novel protein therapeutics

· Customer Testimonial

High throughput screening of novel protein therapeutics

Integrating an INTEGRA VIAFLO 96 multichannel pipette into their high throughput expression facility has enabled Molecular Partners (Zurich, Switzerland) to streamline the discovery and development of a novel class of targeted protein therapeutics termed DARPins.

Rate this article

CAPTCHA